| Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy C Krishna, RG DiNatale, F Kuo, RM Srivastava, L Vuong, D Chowell, ... Cancer cell 39 (5), 662-677. e6, 2021 | 254 | 2021 |
| New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia K Trpkov, O Hes, SR Williamson, AJ Adeniran, A Agaimy, ... Modern Pathology 34 (7), 1392-1424, 2021 | 214 | 2021 |
| Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia K Trpkov, SR Williamson, AJ Gill, AJ Adeniran, A Agaimy, ... Modern Pathology 34 (6), 1167-1184, 2021 | 184 | 2021 |
| PERK (EIF2AK3) REGULATES PROINSULIN TRAFFICKING AND QUALITY CONTROL IN THE SECRETORY PATHWAY S Gupta The Pennsylvania State University, Graduate Program in Molecular Medicine, 2010 | 159 | 2010 |
| Sarcomatoid renal cell carcinoma: biology, natural history and management KA Blum, S Gupta, SK Tickoo, TA Chan, P Russo, RJ Motzer, JA Karam, ... Nature Reviews Urology 17 (12), 659-678, 2020 | 133 | 2020 |
| Magnetic resonance elastography: a novel technique for the detection of hepatic fibrosis and hepatocellular carcinoma after the Fontan operation JT Poterucha, JN Johnson, MY Qureshi, PW O’Leary, PS Kamath, ... Mayo Clinic Proceedings 90 (7), 882-894, 2015 | 121 | 2015 |
| Sarcomatoid urothelial carcinoma of the bladder: analysis of 28 cases with emphasis on clinicopathologic features and markers of epithelial-to-mesenchymal transition J Sanfrancesco, JK McKenney, MZ Leivo, S Gupta, P Elson, DE Hansel Archives of pathology & laboratory medicine 140 (6), 543-551, 2016 | 97 | 2016 |
| Comprehensive next-generation sequencing unambiguously distinguishes separate primary lung carcinomas from intrapulmonary metastases: comparison with standard histopathologic … JC Chang, D Alex, M Bott, KS Tan, V Seshan, A Golden, JL Sauter, ... Clinical Cancer Research 25 (23), 7113-7125, 2019 | 85 | 2019 |
| TFEB-VEGFA (6p21. 1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management S Gupta, SH Johnson, G Vasmatzis, B Porath, JG Rustin, P Rao, ... Modern Pathology 30 (7), 998-1012, 2017 | 83 | 2017 |
| PERK in beta cell biology and insulin biogenesis DR Cavener, S Gupta, BC McGrath Trends in Endocrinology & Metabolism 21 (12), 714-721, 2010 | 78 | 2010 |
| Hyperthermia induces the ER stress pathway X Xu, S Gupta, W Hu, BC McGrath, DR Cavener PloS one 6 (8), e23740, 2011 | 77 | 2011 |
| Incidence of succinate dehydrogenase and fumarate hydratase–deficient renal cell carcinoma based on immunohistochemical screening with SDHA/SDHB and FH/2SC S Gupta, AA Swanson, YB Chen, T Lopez, D Milosevic, BR Kipp, ... Human pathology 91, 114-122, 2019 | 75 | 2019 |
| PERK regulates the proliferation and development of insulin-secreting beta-cell tumors in the endocrine pancreas of mice S Gupta, B McGrath, DR Cavener PloS one 4 (11), e8008, 2009 | 75 | 2009 |
| Role in tumor growth of a glycogen debranching enzyme lost in glycogen storage disease S Guin, C Pollard, Y Ru, C Ritterson Lew, JE Duex, G Dancik, C Owens, ... Journal of the National Cancer Institute 106 (5), dju062, 2014 | 72 | 2014 |
| Acute ablation of PERK results in ER dysfunctions followed by reduced insulin secretion and cell proliferation D Feng, J Wei, S Gupta, BC McGrath, DR Cavener BMC cell biology 10, 1-12, 2009 | 65 | 2009 |
| JAK2/PD-L1/PD-L2 (9p24. 1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical management S Gupta, JC Cheville, AA Jungbluth, Y Zhang, L Zhang, YB Chen, ... Modern Pathology 32 (9), 1344-1358, 2019 | 62 | 2019 |
| Low-grade oncocytic tumor of kidney (CK7-positive, CD117-negative): incidence in a single institutional experience with clinicopathological and molecular characteristics O Kravtsov, S Gupta, JC Cheville, WR Sukov, R Rowsey, ... Human pathology 114, 9-18, 2021 | 50 | 2021 |
| Mammalian target of rapamycin complex 2 (mTORC2) is a critical determinant of bladder cancer invasion S Gupta, AM Hau, JR Beach, J Harwalker, E Mantuano, SL Gonias, ... PloS one 8 (11), e81081, 2013 | 50 | 2013 |
| TFEB Expression Profiling in Renal Cell Carcinomas Gupta S, Argani P, Chen YB, Tickoo S, Fine S, Gopalan A, Al-Ahmadie HA ... Modern Pathology 32 (Supplement 2), 61-62, 2019 | 47* | 2019 |
| Phase II study of neoadjuvant nivolumab in patients with locally advanced clear cell renal cell carcinoma undergoing nephrectomy MI Carlo, K Attalla, Y Mazaheri, S Gupta, O Yildirim, SJ Murray, ... European urology 81 (6), 570-573, 2022 | 44 | 2022 |